ResMed Announces Participation in the 24th Annual Macquarie Australia Conference

ResMed Announces Participation in the 24th Annual Macquarie Australia Conference
ResMed (NYSE: RMD, ASX: RMD) today announced Brett Sandercock, chief financial officer, will present virtually at the Macquarie Australia Conference on Tuesday, May 3, 2022, beginning at approximately 8:45 a.m. (Australian Eastern Standard Time) via video webcast.

More information about this event, including access to the live webcast, may be accessed by visiting http://investor.resmed.com. The webcast replay will be available approximately 24 hours after the live webcast ends and will be accessible through August 1, 2022.

About ResMedAt ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries. To learn more, visit ResMed.com and follow @ResMed.